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We have previously shown that the 8E3 site is an essential element for transcriptional activation by the
human T-celH receptor (TCR) 8 enhancer and identified two factors, NF-8E3A and NF-8E3C, that bound to
overlapping core (TGTGGTTT) and E-box motifs within 8E3. In this study, we show that protein binding to
the core motif is necessary but not sufficient for transcriptional activation by the 8E3 element. In contrast,
protein binding to the E-box motif does not contribute significantly to enhancer activity. A similar core motif
present within the enhancers of T-celi-tropic murine retroviruses has been shown to contribute to transcrip-
tional activity of the viral long terminal repeat in T lymphocytes and to viral T-cell tropism. We therefore
determined the relationship between the nuclear factors that bind to the TCR 8 and Moloney murine leukemia
virus core motifs. On the basis of electrophoretic mobility shift binding and competition studies, biochemical
analysis of affinity-labeled DNA-binding proteins, and the binding of a purified core binding factor, the proteins
that bound to the TCR 8 core site were indistinguishable from those that bound to the murine leukemia virus
core site. These data argue that DNA-binding proteins that interact with the core site of murine leukemia virus
long terminal repeats and contribute to viral T-celH tropism also play an essential role in the T-cell-specific
expression of cellular genes.
The rearrangement and expression of T-cell receptor
(TCR) genes is regulated in a time- and lineage-specific
fashion during T-lymphocyte development (5, 16). In order
to elucidate the basis for developmental regulation, much
effort has focused on identification of the cis-acting DNA
sequence elements that are required to drive the transcrip-
tion of these genes as well as the transcription factors that
functionally interact with such sequences. These studies
have resulted in the characterization of numerous T-cell-
specific, lymphoid-specific, and ubiquitously expressed fac-
tors that activate transcription via their interaction with
specific sites within enhancer elements that flank TCR
constant-gene segments (reviewed in reference 12).
We have previously identified and characterized a T-cell-
specific transcriptional enhancer located within the J83-C8
intron of the human TCR 8 gene (17). We further defined a
30-bp element within the enhancer, denoted bE3, that binds
multiple nuclear factors and is essential for significant tran-
scriptional activation by the enhancer (18). Within SE3,
overlapping binding sites were defined for two distinct
factors, NF-bE3A and NF-bE3C. NF-bE3A is found in
T-cell nuclear extracts and in some B-cell nuclear extracts
and binds to a DNA sequence motif, TGTGGTTT, that is
highly related to the viral core consensus sequence present
in the enhancers of many animal viruses (20). NF-bE3C is
ubiquitously expressed and binds to an overlapping DNA
sequence element that is related to the immunoglobulin
E-box motif (24). The binding site for a second ubiquitously
expressed BE3 binding factor, NF-bE3B, is distinct from
those of NF-BE3A and NF-bE3C but has not been precisely
mapped. We showed that the introduction of a 3-bp substi-
* Corresponding author.
tution that inhibits the binding of NF-BE3A and NF-bE3C
but does not affect binding of NF-bE3B eliminates transcrip-
tional activation of the Vj1 promoter by a single copy of the
6E3 site and reduces transcriptional activation of this pro-
moter by the intact TCR 8 enhancer by 90 to 95% (18). From
the restricted expression pattern of NF-bE3A, we suggested
that this factor, rather than NF-BE3C, was essential for
transcriptional activation through the 8E3 element.
Studies of T-cell-tropic murine retroviruses have demon-
strated that the viral core motif contributes to the transcrip-
tional activity of the viral long terminal repeat (LTR) in T
lymphocytes (2, 22, 26) and is a powerful determinant of the
observed T-cell tropism of these viruses (21). Factors
present in T-cell nuclear extracts (i.e., SL3-3 enhancer-
binding factor-i [SEF-1] and core binding factor [CBF]) that
bind to the core motifs of a number of murine retroviruses
have been described (2, 26-28). Recently, CBF has recently
been purified to homogeneity from nuclear extracts prepared
from calf thymus tissue (28). In addition, a factor called
polyomavirus enhancer-binding protein 2 (PEBP2) that binds
with similar specificity to the core site of the polyomavirus
enhancer has recently been purified from nuclear extracts of
H-ras-transformed NIH 3T3 fibroblasts (9).
In this report, we further examine transcriptional activa-
tion through the BE3 site of the TCR 8 enhancer and explore
the relationship between NF-bE3A and factors that bind to
the core motif of murine leukemia virus enhancers. Our
results indicate that the binding of NF-bE3A, rather than
NF-bE3C, correlates with transcriptional activation through
the bE3 site. An intact binding site for NF-BE3A is necessary
for transcriptional activation through bE3 but is nevertheless
not sufficient for transcriptional activation through this site.
Furthermore, we show by multiple criteria that the factors
that bind to the bE3 core element are indistinguishable from
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6E3 45bp wild-type GGTGAGTGAGCAATGCATGTGGTTTCCAACCGTTAATGCTAGAGT
6E3 35bp wild-type -----------------------------------
6E3 35bp mAC -----------ACC---------------------
6E3 35bp mC -------TC--------------------------
6E3 20bp wild-type ---------------------
6E3 20bp mC ---TC----------------
MoMILV core 18bp -G--ATC------AAG--
MoMLV core 2lbp G--ATC------AAG--GTTC
FIG. 1. Nuclear protein-binding sites tested. The actual oligonu-
cleotides used in this study included flanking sequences appended to
facilitate cloning and radiolabeling, as described in Materials and
Methods. The extents of the BE3 binding site, as defined by DNase
I footprinting, and the NF-8E3A and NF-bE3C binding sites, as
defined by methylation interference, are shown. mAC designates a
mutation that diminishes the formation of complexes BE3A and
&E3C. mC designates a mutation that diminishes the formation of
complex SE3C.
the factors that bind to the Moloney murine leukemia virus
(MoMLV) core element. Together, these data argue that
cellular genes specifically expressed in T lymphocytes and
viral genes of T-cell-tropic retroviruses are regulated by
common DNA-binding proteins.
MATERIALS AND METHODS
Plasmids and oligonucleotides. The binding sites tested in
this study are shown in Fig. 1. Complementary oligonucle-
otides representing the 35-bp bE3 and bE3IAC sites (see Fig.
1 legend for nomenclature) were 40 nucleotides long, includ-
ing appended BamHI- and XbaI-compatible overhangs.
Complementary oligonucleotides representing the 35-bp
bE3mc site were 39 nucleotides long, including appended
BamHI-compatible overhangs. Complementary oligonucle-
otides representing the 20-bp SE3 and bE3mc sites were 24
nucleotides long, including XbaI-compatible overhangs.
Complementary oligonucleotides representing the 18-bp
MoMLV core site were 18 nucleotides long and generated
blunt ends. The 45-bp BE3 site was generated by using the
oligonucleotide 5'-ACTCTAGCATTAACGGTTGGAAACC
ACATGCATTGCTCACTCACC-3' and a 15-mer primer,
5'-GGTGAGTGAGCAATG-3', for the synthesis of the sec-
ond strand, as described previously (18). The 21-bp MoMLV
core site was embedded within bE3 site-flanking sequence to
generate the 45-mer 5'-actctagcaGAACTGCTTACCACAG
ATATCcattgctcactcacc-3' (uppercase letters represent Mo-
MLV sequence, and lowercase letters represent 8E3 site-
flanking sequence); second-strand synthesis was accom-
plished by using the 15-mer primer noted above. The plasmid
V81-CAT and versions of this plasmid carrying monomeric
and trimeric 35-bp bE3 site, monomeric 35-bp bE3mAc site
(previously called mbE3), and the intact 370-bp TCR 8
enhancer (previously called fragment A) have been de-
scribed before (18). Oligonucleotides representing the 35-bp
bE3mc site were treated with T4 polynucleotide kinase (New
England Biolabs, Beverly, Mass.), annealed, and ligated into
BamHI-digested and phosphatase-treated V81-CAT. Oligo-
nucleotides representing the 20-bp SE3 site were treated with
T4 polynucleotide kinase, annealed, and self-ligated, and
trimers were gel purified and cloned into XbaI-digested and
phosphatase-treated V8J-CAT. The structures of all con-
structs were confirmed by dideoxynucleotide sequence anal-
ysis (19).
Transfections and CAT assays. For chloramphenicol ace-
tyltransferase (CAT) assays, the human T-cell line Jurkat
was transfected with CsCl-purified plasmid DNA by using
Lipofectin (GIBCO-BRL, Gaithersburg, Md.) as described
previously (17). Acetylation of [14C]chloramphenicol (Du
Pont-New England Nuclear, Boston, Mass.) was assayed as
described before (17) and quantified with a Betascope (Be-
tagen, Waltham, Mass.).
DNA-binding assays. The preparation of nuclear extracts,
radiolabeling of binding-site probes with the Klenow frag-
ment of DNA polymerase I (New England Biolabs) and
[a-32P]dGTP (Du Pont-NEN), and electrophoretic mobility
shift assays (EMSAs) were done as described previously
(18).
Analysis of affinity-labeled DNA-binding proteins. In situ
UV-induced cross-linking with bromodeoxyuridine-substi-
tuted probes was performed as described previously (18).
Affinity-labeled proteins were analyzed by partial proteoly-
sis with N-chlorosuccinimide (Sigma Chemical Co., St.
Louis, Mo.) as described before (13). Briefly, UV-cross-
linked species were resolved by sodium dodecyl sulfate-
7.5% polyacrylamide gel electrophoresis (SDS-7.5% PAGE),
and after autoradiography, appropriate slices of gel were
excised. Gel slices were incubated with shaking at room
temperature in 1 ml of each of the following solutions: water,
twice for 10 min each; urea (1 g)-water (1 ml)-acetic acid (1
ml), twice for 10 min each; 15 mM N-chlorosuccinimide in
urea-water-acetic acid, once for 30 min; water, twice for 10
min each; and Laemmli sample buffer (11), three times for 30
min each. Gel slices were then heated to 100°C and loaded
onto a 10% polyacrylamide gel, and radiolabeled fragments
were resolved by electrophoresis (11).
Partial purification of NF-8E3A. A DNA affinity column
was prepared by coupling multimerized 20-bp SE3 site
oligonucleotides to CNBr-activated Sepharose (Pharmacia,
Piscataway, N.J.) as described before (8). Crude nuclear
extract from the Jurkat T-cell line (3.5 mg of protein) was
dialyzed against 20 mM HEPES (N-2-hydroxyethylpipera-
zine-N'-2-ethanesulfonic acid, pH 7.4)-250 mM KCl-0.1%
polyoxyethylene-9-lauryl ether (Sigma)-20% glycerol-0.2
mM EDTA-0.5 mM phenylmethylsulfonyl fluoride-0.5 mM
dithiothreitol, incubated with 450 ,ug of poly(dI-dC) for 20
min at 40C, and passed over a 0.5-ml affinity column. After
extensive washing in the starting buffer, DNA-binding pro-
teins were eluted first with 600 mM KCl and then with 1 M
KCl in the starting buffer. NF-bE3C eluted primarily in the
600 mM fraction, whereas NF-bE3A eluted in the 1 M KCl
fraction. The concentration of protein in the latter fraction
was 30 ,ug/ml.
RESULTS
We previously used methylation interference to define
overlapping binding sites for two distinct factors, NF-BE3A
and NF-bE3C, within the 8E3 element of the TCR 8 en-
hancer (Fig. 1). A 3-bp substitution (changing TGG to ACC)
was shown to abrogate the binding of NF-8E3A and diminish
the binding of NF-8E3C and to dramatically reduce tran-
scriptional activation by either a single copy of the BE3
element or an otherwise intact TCR 8 enhancer (18). In order
to discriminate between the roles of NF-8E3A and NF-8E3C
binding in transcriptional activation, we generated oligonu-
cleotides representing either 20 bp of wild-type BE3 se-
quence or a 20-bp site with a 2-bp substitution (CA to TC)
predicted to selectively eliminate the binding of NF-8E3C
(BE3mc). We then used EMSA to test the ability of the
BE3mc oligonucleotide to serve as a competitor for the
MOL. CELL. BIOL.
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FIG. 2. Nuclear factor binding to a mutant bE3 site. Radiola-
beled 20-bp BE3 and BE3mc binding sites (0.5 ng) were incubated
with 4 ,ug of Jurkat nuclear extract in the absence of competitor or
in the presence of increasing amounts of competitor (15-, 50-, and
150-fold molar excess). DNA-protein complexes were resolved by
electrophoresis.
formation of complexes between the radiolabeled BE3 probe
and factors in Jurkat T-cell nuclear extract (Fig. 2).
In the absence of any unlabeled oligonucleotide competi-
tor, two complexes, 8E3A and BE3C, were detected with the
radiolabeled 20-bp SE3 site probe; this probe does not bind
NF-8E3B. Both of the complexes detected were specific,
since efficient competition was observed with an excess of
unlabeled 8E3 site but not with equivalent amounts of the
heterologous SE4 site. The mutant bE3mc site was at least as
efficient as the wild-type BE3 site in competing for the
formation of the 6E3A complex. However, the bE3mc site
did not compete for the formation of the BE3C complex at
any concentration tested. Furthermore, a radiolabeled
bE3mc probe detected abundant levels of the 8E3A complex
but failed to detect the 8E3C complex when used in a direct
binding experiment (Fig. 2). Thus, the 2-bp substitution
within the NF-bE3C binding site eliminates the binding of
NF-bE3C but does not significantly affect the binding of
NF-SE3A.
In order to evaluate the functional consequences of this
mutation, wild-type and mutant sites were cloned upstream
of the V81 promoter in the enhancer-dependent test con-
struct V8,1-CAT, and constructs were transiently transfected
into the Jurkat T-cell line to measure their activities (Fig. 3).
Consistent with previous experiments, a trimer of a 35-bp
BE3 site was a potent enhancer of transcription from the Vjl
promoter (40.1-fold induction) and displayed a potency
similar to that of the intact TCR 8 enhancer (56.3-fold
induction). A single copy of this site resulted in significant,
although weaker, transcriptional activation as well (12.1-fold
induction). In contrast, a single copy of a 35-bp BE3 site
carrying the 3-bp substitution that affects both NF-bE3A and
NF-bE3C binding (8E3IAc) displayed no activity in this
assay (0.3-fold induction). However, a single copy of a 35-bp
mutant site that selectively eliminates NF-bE3C binding
(8E3mc) displayed enhancer activity that was essentially
identical to that of the wild-type BE3 site (12.7-fold induc-
tion). Taken together, the results of EMSA and CAT assays
with the bE3 c and bE3mc sites argue pursuasively that
binding of NF-bE3A rather than NF-bE3C is required for
transcriptional activation through the 6E3 site.
We also examined the activity of the 20-bp wild-type 8E3
site in this experiment (Fig. 3). Strikingly, the 20-bp BE3 site
failed to significantly augment transcription even when
tested as a trimer (2.2-fold induction), despite the fact that
this site efficiently bound NF-bE3A (Fig. 2). Since the 20-bp
8E3 site is missing 6 bp at its 3' end that are included in the
SE3 footprint (Fig. 1), these data suggest that transcriptional
activation through the BE3 site requires the cooperation of
NF-bE3A with an additional factor that binds in the 3'
portion of the BE3 site. This activity might be mediated by
the ubiquitous NF-8E3B, which does not bind to the 20-bp
8E3 site in EMSA. Alternatively, this activity might be
mediated by a distinct factor that has gone undetected in
previous experiments.
NF-bE3A binds to a sequence within 8E3, TGTGGTTT,
that is highly related to the core consensus element present
within the transcriptional enhancers of many animal viruses,
including the long terminal repeats (LTRs) of the murine
leukemia viruses. Previous studies have shown that the core
sequence plays an important role in driving T-cell-specific
gene expression and determining the T-cell tropism of the
SL3-3 virus and MoMLV and have identified factors present
in T-cell nuclear extracts (SEF-1 and CBF) that bind to the
core element (2, 21, 22, 26-28). The core element present
within the MoMLV LTR, TGTGGTAA, is similar to but
nevertheless distinct from the related element within the
TCR 8 enhancer that is recognized by NF-&E3A. We there-
fore sought to examine the relationship between NF-BE3A
and the factors that interact with the MoMLV core element.
We used EMSA to compare the nuclear complexes formed
between factors present in crude Jurkat T-cell nuclear ex-
tract and radiolabeled 8E3 and MoMLV core site oligonu-
cleotide probes (Fig. 4). High levels of two specific com-
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FIG. 3. Transcriptional activation by wild-type and mutant 8E3 binding sites. Monomers and trimers of the indicated binding sites were
tested for activation of the V81 promoter in the test construct V81-CAT. Constructs were transfected in triplicate into the Jurkat T-cell line,
and values for percent chloramphenicol acetylation were averaged and then normalized to the activity of the enhancerless V81-CAT construct.
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crude nuclear extract affinity column eluate
FIG. 4. Nuclear factor binding to bE3 and MoMLV core binding
sites. Radiolabeled 45-mer BE3 (8) and MoMLV core (M) binding
sites (0.8 ng) were incubated with 2 pLg of Jurkat nuclear extract or
60 ng of affinity column eluate in the absence of competitor or in the
presence of a 50-fold molar excess of unlabeled bE3 20-bp (8),
MoMLV core 18-bp (M), or BE3"Ac 35-bp (Bn'AC) competitors.
DNA-protein complexes were resolved by electrophoresis. The
BE3A and ME3C complexes are marked. The SE3B complex is
normally detected with this SE3 probe and migrates slightly faster
than the abundant nonspecific complex, but is not easily visualized
in this experiment.
site probe. The inclusion of an excess of unlabeled BE3 site
oligonucleotide resulted in efficient competition for the 8E3A
complex and partial competition for the SE3C complex.
Inclusion of an equivalent amount of unlabeled MoMLV
core site oligonucleotide resulted in almost complete inhibi-
tion of the BE3A complex but failed to inhibit the BE3C
complex. Unlabeled 8E3IAC oligonucleotide did not com-
pete in either case. Consistent with these observations, a
radiolabeled MoMLV core site probe formed a DNA-protein
complex with an electrophoretic mobility identical to that of
8E3A, and the formation of this complex was inhibited by
excess unlabeled 8E3 and MoMLV core oligonucleotides but
not by the SE3IAc oligonucleotide. This analysis suggests
that NF-bE3A binds to both the SE3 site and the MoMLV
core site.
A number of experiments were conducted to ascertain
whether the complexes detected with the radiolabeled 8E3
and MoMLV probes that were of identical electrophoretic
mobility indeed contained the same DNA-binding proteins.
A preparation of partially purified SE3 binding factors was
generated by passing crude Jurkat nuclear extract over an
affinity column consisting of multimerized BE3 site oligonu-
cleotide and eluting with a step salt gradient. A fraction
enriched for NF-bE3A was examined by EMSA with radio-
labeled BE3 and MoMLV core site probes and the relevant
unlabeled competitors (Fig. 4). The results obtained were
identical to those described above using crude nuclear
extract. Thus, partial purification did not resolve NF-8E3A
from the MoMLV core binding activity, even though the
step gradient elution effectively resolved NF-SE3A from
NF-bE3C.
A more direct comparison of the DNA-binding proteins
that interact with the BE3 and MoMLV sites was made by
DNA-protein cross-linking studies. We have previously af-
finity labeled the binding component of NF-bE3A by UV-
induced cross-linking to a bromodeoxyuridine-substituted
SE3 probe (18). SDS-PAGE revealed three affinity-labeled
polypeptides with mobilities in the 70- to 11O-kDa range. To
determine whether a similar array of polypeptides were
bound by the MoMLV core site, we compared the polypep-





FIG. 5. Comparison of affinity-labeled NF-bE3A and MoMLV
core binding factors. Bromodeoxyuridine-substituted, radiolabeled
BE3 (8) and MoMLV core (M) 45-mers were incubated with either
Jurkat crude nuclear extract or affinity column eluate. Complexes
were resolved by electrophoresis, UV irradiated in situ, and then
analyzed by SDS-7.5% PAGE. Duplicate samples were processed
for N-chlorosuccinimide cleavage (see Fig. 6). Affinity-labeled spe-
cies labeled 1, 2, and 3 correspond to the similarly labeled 100-kDa,
90-kDa, and 78-kDa species, respectively, analyzed in Fig. 6.
tides labeled by cross-linking to bromodeoxyuridine-substi-
tuted SE3 site and MoMLV core site probes by SDS-PAGE
(Fig. 5). Highly similar arrays of polypeptides were detected
by the two probes with either crude Jurkat nuclear extract or
the partially purified -fraction containing NF-bE3A activity
(see above) used as the source of DNA-binding proteins.
To further explore the relationships among the various
polypeptides that were affinity labeled by the two probes, the
affinity-labeled polypeptides were individually excised from
the polyacrylamide gel and partially proteolyzed by treat-
ment with N-chlorosuccinimide, and the labeled cleavage
products were reanalyzed by SDS-PAGE (Fig. 6). Analysis
MoMLV MoMLV
probe: 6E3 core 6E3 core






FIG. 6. Partial proteolysis of affinity-labeled NF-bE3A and Mo-
MLV core binding factors. Species of 100, 90, and 78 kDa (lanes 1,
2, and 3, respectively, corresponding to species 1, 2, and 3 in Fig. 5)
affinity labeled by BE3 and MoMLV core binding sites were excised
from a 7.5% polyacrylamide gel and partially digested with N-chlo-
rosuccinimide or mock digested, and the products were analyzed by
SDS-10% PAGE.
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FIG. 7. Interaction of purified core binding factor with the bE3
and MoMLV core sites. Radiolabeled 45-mer bE3 and MoMLV core
binding sites (1.0 ng) were incubated with 1 Ll of purified CBF in the
absence of competitor or in the presence of a 50-fold molar excess of
unlabeled bE3 20-bp (8), MoMLV core 18-bp (M), or bE3mAc 35-bp
(8AC) competitor. DNA-protein complexes were resolved by elec-
trophoresis. The arrow marks the mobility of the ME3A complex. A
specific complex of this mobility was detected at low levels in this
experiment.
of the uncleaved material served to monitor the purity of the
preparations of affinity-labeled polypeptides; only the largest
BE3 labeled species showed significant contamination with
other forms. Cleavage with N-chlorosuccinimide revealed a
common pattern of affinity-labeled peptide fragments for all
of the 8E3-labeled and MoMLV core-labeled polypeptides.
These data indicate that the three different size species
affinity labeled by a single probe are all highly related to each
other and that the proteins in Jurkat nuclear extract that bind
to the MoMLV core site probe are likely identical to those
that bind to the BE3 site probe.
A preparation of CBF that binds to the MoMLV core site
has recently been purified from nuclear extracts of calf
thymus (28). This preparation consists of a series of poly-
peptides in the 19- to 35-kDa range; heterogeneity may result
from proteolytic degradation. We compared the ability of the
purified CBF to bind to radiolabeled 8E3 and MoMLV core
site probes in an EMSA (Fig. 7). We found that purified CBF
bound specifically to both probes, since competition was
observed when an excess of the homologous binding site but
not an excess of the bE31Ac site was used. Unlabeled 5E3
served as a more efficient competitor for complex formation
than unlabeled MoMLV core, suggesting that CBF binds
with higher affinity to the former site. This binding hierarchy
is identical to that observed for NF-bE3A in Jurkat nuclear
extract. Notably, the mobility of the major complex formed
between either probe and the purified calf thymus CBF was
quite different from the mobility of the NF-bE3A complex.
However, a complex with a mobility identical to that of
NF-bE3A was detected at low levels in this experiment
(arrow, Fig. 7).
DISCUSSION
In previous studies, we identified the BE3 site as an
essential element for transcriptional activation by the human
TCR 8 enhancer and identified a DNA-binding factor, NF-
BE3A, that is preferentially expressed in T lymphocytes and
that specifically interacts with the motif TGTGG'Tl''F within
BE3 (17, 18). We also identified a ubiquitous factor, NF-
8E3C, that binds to the overlapping motif GCATGTGGTT.
In this study, we used mutagenesis to assess the relative
contributions of NF-8E3A and NF-BE3C binding to tran-
scriptional activation through the 8E3 site. We found that
transcriptional activation requires an intact binding site for
NF-8E3A but not for NF-8E3C. Furthermore, we found that
transcriptional activation requires additional sequences
within BE3 that probably bind a distinct, uncharacterized
nuclear factor. Thus, protein binding to the core site is
necessary but not sufficient for transcriptional activation
through 8E3. We also explored the relationship between
NF-BE3A and previously characterized nuclear factors that
interact with the highly related core motif of T-cell-tropic
murine retroviruses by comparing the factors that bound to
the 8E3 motif with those that bound to the MoMLV core
site. On the basis of EMSA direct-binding and competition
studies, biochemical analysis of affinity-labeled DNA-bind-
ing proteins, and the binding of a purified CBF, we could not
distinguish the proteins that interact with the 8E3 and
MoMLV core sites. These data provide evidence that DNA-
binding proteins that interact with the core site of murine
leukemia virus LTRs and play an important role in viral
T-cell tropism also play an essential role in the T-cell-specific
expression of the TCR 8 gene.
We and others have noted that the enhancers of numerous
genes that are specifically expressed in T lymphocytes
display sequences that are identical or very closely related to
the BE3 site TGTGGT' l motif (10, 15, 18, 23, 27, 28). There
are perfect matches to this sequence within the murine and
human TCR I enhancers (6, 10, 15, 25), a sequence with a
perfect match and one with a single mismatch (TGTGGTCT)
within the murine TCR y enhancer (23), and a sequence with
a single mismatch (TGTGGTTA) within the CD3E enhancer
(4). Purified CBF binds to both sites within the TCR y
enhancer (28). Furthermore, the site within the CD3e en-
hancer is identical to a binding site within the SL3-3 en-
hancer that binds a factor, called SEF-1, detected in T-cell
nuclear extracts (26). This factor also interacts with the
sequence TGTGGTTT' (27) and is therefore probably identi-
cal to NF-8E3A. Thus, we predict that all of these sites are
capable of interacting with the same DNA-binding proteins.
These core sequences are located within segments of the
TCR -y and TCR 1 enhancers that are important for tran-
scriptional activity in T lymphocytes (6, 10, 15, 23, 25). Our
previous results indicate that the introduction of a mutation
into the core site of an otherwise intact TCR 8 enhancer
results in a 90 to 95% reduction in transcriptional activation
by the enhancer (18). Thus, nuclear protein binding to core
motifs may play a general and important role in T-cell-
specific expression of cellular genes.
The present study argues that the ability of an isolated BE3
site to serve as an enhancer depends not only on protein
binding to the core site, but probably also on protein binding
to additional sequences within SE3 as well. One candidate
for this protein is a previously detected BE3 binding factor,
NF-8E3B, that displays a broad tissue distribution (18).
Since NF-8E3B binding is not affected by mutations that
diminish the binding of NF-8E3A, and since NF-8E3B does
not bind to the 20-bp 8E3 site, this factor likely binds to
sequences within 8E3 that are distinct from the binding site
for NF-BE3A. It should be possible to address the role of
NF-BE3B by defining its binding site in the methylation
interference assay and testing mutations that interfere with
binding for effects on transcriptional activation by the 35-bp
8E3 site. As an alternative approach, random mutagenesis in
the 3' portion of 8E3 has the potential to define the binding
site for a factor that functionally cooperates with NF-8E3A
but has not been detected in EMSA experiments.
Our data indicate that NF-SE3C binding to the E-box
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motif that overlaps the NF-bE3A binding site does not play
a significant role in transcriptional activation through &E3,
since a mutation that selectively destroyed this site did not
affect enhancer activity. We attempted to construct a recip-
rocal mutation that eliminated the binding of NF-8E3A
without disturbing NF-bE3C binding but did not identify a
mutation with these characteristics because of the extensive
overlap of the two sites. As a result, it is formally possible
that binding to the E motif could mediate weak transcrip-
tional activation in this system. The ubiquitous factors USF,
TFE3, and TFEB should all be capable of interacting with
this site (1, 3, 7). USF is typically detected by EMSA with
crude nuclear extracts, and it is therefore possible that
NF-8E3C is identical to USF. Protein binding to the E motif
might occur in vitro but not in vivo, a question that could be
addressed by in vivo footprinting (14).
Our data indicate that both the 8E3 and MoMLV core sites
bind NF-8E3A from crude nuclear extracts of the Jurkat
T-cell line and bind CBF purified from nuclear extracts of
calf thymus. However, the precise relationship between
NF-bE3A and CBF remains to be established. Affinity
labeling of the DNA-binding component of NF-BE3A yields
a series of protein-DNA complexes of 78, 90, and 100 kDa.
While the precise contribution of the covalently bound
oligonucleotide to the measured SDS-PAGE mobility of the
complexes is not known, this contribution is likely to be no
more than about 10 kDa. Thus, NF-bE3A is significantly
larger than the predominant polypeptides in the CBF prep-
aration, which range in size from 19 to 35 kDa. Extensive
proteolysis of the polypeptides in the CBF preparation could
be one explanation for this difference. In support of this
interpretation, previous studies have shown that SEF-1,
which is probably identical to NF-bE3A, is highly sensitive
to proteolytic degradation and have shown that a number of
proteases can convert SEF-1 to a fragment that forms a
protein-DNA complex with a much higher electrophoretic
mobility than the intact SEF-1-DNA complex (26). Since
incubation of CBF with radiolabeled BE3 and MoMLV core
site probes revealed low levels of a DNA-protein complex
with a mobility identical to that of NF-bE3A (arrow, Fig. 7),
it is possible that the CBF preparation contained small
amounts of intact protein. We did not attempt to use partial
proteolysis for a biochemical comparison of the predominant
affinity-labeled NF-bE3A and CBF forms because the small-
est fragment of affinity-labeled NF-BE3A generated by
N-chlorosuccinimide treatment was 34 kDa, the same appar-
ent size as the largest of the polypeptides in the CBF
preparation.
NF-&E3A and CBF have similar relative affinities for the
&E3 and MoMLV core sites, as both appear to bind the 8E3
site TGTGGlTT more efficiently than the MoMLV site
TGTGGTAA. Consistent with this result, 95% of the sites
bound by CBF in an in vitro binding-site selection assay
displayed a T in the seventh position (TGTGG1T) (3a).
Thus, NF-BE3A and CBF display closely related DNA-
binding specificities. However, a more definitive evaluation
of the relationship between NF-bE3A and CBF will require
either the purification and biochemical characterization of
NF-bE3A or the use of antibodies raised against purified
CBF to establish the immunological cross-reactivity of the
two species.
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